Author Correction: Apolipoprotein C1 promotes glioblastoma tumorigenesis by reducing KEAP1/NRF2 and CBS-regulated ferroptosis.
Saved in:
| Title: | Author Correction: Apolipoprotein C1 promotes glioblastoma tumorigenesis by reducing KEAP1/NRF2 and CBS-regulated ferroptosis. |
|---|---|
| Authors: | Zheng XJ; The State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Beijing, 100050, China.; Key Laboratory of Drug Target Research and Drug Screen, Institute of Materia Medica, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, 100050, China., Chen WL; Department of Neurosurgery, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, 100730, China., Yi J; Department of Clinical Laboratory, Peking Union Medical College Hospital, Beijing, 100730, China., Li W; The State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Beijing, 100050, China.; Key Laboratory of Drug Target Research and Drug Screen, Institute of Materia Medica, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, 100050, China., Liu JY; The State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Beijing, 100050, China.; Key Laboratory of Drug Target Research and Drug Screen, Institute of Materia Medica, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, 100050, China., Fu WQ; The State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Beijing, 100050, China.; Key Laboratory of Drug Target Research and Drug Screen, Institute of Materia Medica, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, 100050, China., Ren LW; The State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Beijing, 100050, China.; Key Laboratory of Drug Target Research and Drug Screen, Institute of Materia Medica, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, 100050, China., Li S; The State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Beijing, 100050, China.; Key Laboratory of Drug Target Research and Drug Screen, Institute of Materia Medica, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, 100050, China., Ge BB; The State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Beijing, 100050, China.; Key Laboratory of Drug Target Research and Drug Screen, Institute of Materia Medica, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, 100050, China., Yang YH; The State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Beijing, 100050, China.; Key Laboratory of Drug Target Research and Drug Screen, Institute of Materia Medica, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, 100050, China., Zhang YZ; The State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Beijing, 100050, China.; Key Laboratory of Drug Target Research and Drug Screen, Institute of Materia Medica, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, 100050, China., Yang H; The State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Beijing, 100050, China.; Key Laboratory of Drug Target Research and Drug Screen, Institute of Materia Medica, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, 100050, China., Du GH; The State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Beijing, 100050, China.; Key Laboratory of Drug Target Research and Drug Screen, Institute of Materia Medica, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, 100050, China., Wang Y; Department of Neurosurgery, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, 100730, China. ywang@pumch.cn., Wang JH; The State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Beijing, 100050, China. wjh@imm.ac.cn.; Key Laboratory of Drug Target Research and Drug Screen, Institute of Materia Medica, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, 100050, China. wjh@imm.ac.cn. |
| Source: | Acta pharmacologica Sinica [Acta Pharmacol Sin] 2022 Nov; Vol. 43 (11), pp. 3011-3012. |
| Publication Type: | Published Erratum |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: United States NLM ID: 100956087 Publication Model: Print Cited Medium: Internet ISSN: 1745-7254 (Electronic) Linking ISSN: 16714083 NLM ISO Abbreviation: Acta Pharmacol Sin Subsets: MEDLINE; PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
